Valeo Pharma (TSE:VPH) has released an update.
Valeo Pharma Inc., a Canadian pharmaceutical company, has scheduled its earnings call for the second quarter of 2024, which will take place on June 14 after the results are announced on June 13. The conference call will be accompanied by a webcast, with details and registration available online. Valeo specializes in commercializing innovative prescription products in various medical fields, including Respiratory/Allergy, Ophthalmology, and Specialty Hospital Products.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.
